![]() Versea Versea Holdings is a pharmaceutical company focused on the development of molecules for the treatment of inflammatory and other debilitating diseases. | ![]() Zynerba Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. | ||
Founding Date | Founding Date 2016 | Founding Date 2018 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations North Fort Myers, US HQ Bradenton, US Edgewater, US Jacksonville, US Miami, US Orlando, US Pensacola, US see more | Locations Tampa, US HQ Belfast, GB Tampa, US | Locations Devon, US HQ |
Employees | Employees 4,455 | Employees 393% decrease | Employees 2511% decrease |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) N/A | Valuation ($) 70.1 m |
Financial | |||
Net income | Net income ($122.2m) (FY, 2025) | Net income N/A | Net income ($35m) (FY, 2022) |

Versea Holdings is a pharmaceutical company focused on the development of molecules for the treatment of inflammatory and other debilitating diseases.
View company
Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions.
View company